New insights into antibiotic resistance
Treatment of severe infections caused by pathogenic bacteria relies on ‘last resort’ antibiotics, but rising resistance by ‘superbugs’ to most clinically approved drugs leaves patients exposed to possible fatalities. Researchers are focusing on how bacterial cells adapt and resist antimicrobial medications — with a new article focusing on a hospital strain of Acinetobacter baumannii and its cellular response to important antibiotic colistin.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.